Literature DB >> 17157813

Obestatin improves memory performance and causes anxiolytic effects in rats.

Valeria P Carlini1, Helgi B Schiöth, Susana R Debarioglio.   

Abstract

Obestatin is a peptide hormone that is derived from the same polypeptide precursor (preprogrelin) as ghrelin, but it acts in opposing way on ingestive behavior. Our previous studies showed that ghrelin affects memory and anxiety. Here, we studied the possible effects of icv obestatin injection in rats upon memory retention (using two different paradigms), anxiety like behavior (plus maze test), and food intake. Obestatin induces an increase in the percentage of open arms entries (Obestatin 3.0nmol/rat: 61.74+/-1.81), and percentage of time spent in open arms (Obestatin 3.0nmol/rat: 72.07+/-4.21) in relation to the control (33.31+/-1.54; 25.82+/-1.68), indicating an anxiolytic effect. The two doses of obestatin increased latency time in a step down test and the percentage time of novel object exploration, suggesting that the peptide influences learning and memory processes that involve the hippocampus and the amygdala. This report provides evidence indicating that obestatin effects are functionally opposite on anxiety and hunger to the ghrelin effects, while both these related peptides increase memory retention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157813     DOI: 10.1016/j.bbrc.2006.11.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  25 in total

Review 1.  Eating for pleasure or calories.

Authors:  Huiyuan Zheng; Hans-Rudolf Berthoud
Journal:  Curr Opin Pharmacol       Date:  2007-11-26       Impact factor: 5.547

2.  The preproghrelin gene is required for the normal integration of thermoregulation and sleep in mice.

Authors:  Eva Szentirmai; Levente Kapás; Yuxiang Sun; Roy G Smith; James M Krueger
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-04       Impact factor: 11.205

Review 3.  Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion?

Authors:  Carmine Finelli; Maria Carmela Padula; Giuseppe Martelli; Giovanni Tarantino
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

4.  Impact of sustained weight loss achieved through Roux-en-Y gastric bypass or a lifestyle intervention on ghrelin, obestatin, and ghrelin/obestatin ratio in morbidly obese patients.

Authors:  Catia Martins; Louise Kjelstrup; Ingrid L Mostad; Bård Kulseng
Journal:  Obes Surg       Date:  2011-06       Impact factor: 4.129

5.  The gastrointestinal peptide obestatin induces vascular relaxation via specific activation of endothelium-dependent NO signalling.

Authors:  Andrew J Agnew; Emma Robinson; Carmel M McVicar; Adam P Harvey; Imran H A Ali; Jennifer E Lindsay; Denise M McDonald; Brian D Green; David J Grieve
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

6.  Effect of peripheral obestatin on food intake and gastric emptying in ghrelin-knockout mice.

Authors:  I Depoortere; T Thijs; D Moechars; B De Smet; L Ver Donck; T L Peeters
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

7.  Ghrelin in chronic kidney disease.

Authors:  Wai W Cheung; Robert H Mak
Journal:  Int J Pept       Date:  2010-03-17

Review 8.  Ghrelin, des-acyl ghrelin and nesfatin-1 in gastric X/A-like cells: role as regulators of food intake and body weight.

Authors:  Andreas Stengel; Miriam Goebel; Lixin Wang; Yvette Taché
Journal:  Peptides       Date:  2009-11-26       Impact factor: 3.750

9.  Ghrelin and obestatin levels in type 2 diabetic patients with and without delayed gastric emptying.

Authors:  Igor A Harsch; Corinna Koebnick; Atingwa M Tasi; Eckhart Georg Hahn; Peter C Konturek
Journal:  Dig Dis Sci       Date:  2008-12-11       Impact factor: 3.199

10.  Obestatin is associated to muscle strength, functional capacity and cognitive status in old women.

Authors:  Mireia Mora; María Luisa Granada; Elisabet Palomera; Mateu Serra-Prat; Manel Puig-Domingo
Journal:  Age (Dordr)       Date:  2013-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.